avapro has been researched along with Angina at Rest in 1 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biasucci, LM | 1 |
| Lombardi, M | 1 |
| Piro, M | 1 |
| Di Giannuario, G | 1 |
| Liuzzo, G | 1 |
| Crea, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Telmisartan vs Ramipril for Reduction of Inflammation and Recruitment of Endothelial Progenitor Cells After Acute Coronary Syndrome[NCT00702936] | Phase 4 | 50 participants (Anticipated) | Interventional | 2007-11-30 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for avapro and Angina at Rest
| Article | Year |
|---|---|
Irbesartan significantly reduces C reactive protein concentrations after 1 month of treatment in unstable angina.
Topics: Adult; Aged; Angina, Unstable; Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; C-Reacti | 2005 |